ORTHOPOXVIRUS - ANVISA Registration 80142170063

Access comprehensive regulatory information for ORTHOPOXVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80142170063 and manufactured by FUNDAÇÃO OSWALDO CRUZ. The registration is held by FUNDACAO OSWALDO CRUZ with validity until Sep 26, 2032.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ZHEJIANG ORIENT GENE BIOTECH CO., LTD., OSANG HEALTHCARE CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80142170063
Registration Details
ANVISA Registration Number: 80142170063
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

KIT MOLECULAR MONKEYPOX (MPXV) BIO-MANGUINHOS
Risk Class III

Registration Details

80142170063

25351288979202201

33781055000135

Company Information

Brazil
PT: BRASIL

Dates and Status

Sep 26, 2022

26/09/2032

09/18/2025 19:00:01